Santis Pharmaceuticals Private Limited, a active private limited company, was established on 19 April 2010 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100GJ2010PTC060313. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Vertis Pharmaceuticals Private Limited. It upholds a compliant status. Employing 105 professional, Its leadership includes Sanjaykumar Jitendrabhai Jha (Director), Kosha Sanjay Jha (Additional Director). Past directors included Jitendrakumar Baldeobhai Jha, Sandeep Gupta, Ashok Ramprakash Bhatia. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Shop No.413, 4Th Floor, Shanti Arcade, Opp Pushpak Apartment, 132 Foot Ring Road, Naranpura, Ahmedabad, Gujarat, 380013.
U24100GJ2010PTC060313
060313
19 April 2010
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Santis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjaykumar Jitendrabhai Jha | Director | 19 Apr 2010 | Current |
| Kosha Sanjay Jha | Additional Director | 09 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Mar 2022 | Past |
| Pramod Abcsdd | Director | 26 Nov 2021 | Past |
| Pramod Abcsdd | Director | 11 Oct 2021 | Past |
| Pramod Abcsdd | Director | 12 Jul 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Santis Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 14.31% increase. The company also saw a substantial improvement in profitability, with a 87.1% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.51%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Santis Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Santis Pharmaceuticals has a workforce of 105 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Santis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kosha Sanjay Jha was appointed as a Additional Director was appointed as a Additional Director on 09 Apr 2022 & has been associated with this company since 3 years 8 months . was documented.
Progress on Santis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
The activity Santis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ahmedabad. was completed.
Progress on Sanjaykumar Jitendrabhai Jha was appointed as a Director was appointed as a Director on 19 Apr 2010 & has been associated with this company since 15 years 8 months . was documented.
Santis Pharmaceuticals Private Limited was registered on 19 Apr 2010 with Roc Ahmedabad & aged 15 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Santis Pharmaceuticals Private Limited is U24100GJ2010PTC060313.
Santis Pharmaceuticals Private Limited is headquartered at Shop No.413, 4Th Floor, Shanti Arcade, Opp Pushpak Apartment, 132 Foot Ring Road, Naranpura, Ahmedabad, Gujarat, 380013.
Santis Pharmaceuticals Private Limited was incorporated on 19 April 2010.
The current directors of Santis Pharmaceuticals Private Limited are
The primary industry of Santis Pharmaceuticals Private Limited is Manufacturing.
Santis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Santis Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Santis Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX